6 articles
A meta-analysis of 8 studies finds intermittent fasting significantly reduces liver fat and improves key metabolic markers in MASLD patients.
A new narrative review finds IF activates powerful antioxidant pathways, but warns that clinical proof in humans remains thin and short-term.
A systematic review of RCTs finds night fasting windows improve glucose and lipid markers in shift workers, though evidence remains thin.
Burke and Noakes reach surprising common ground on fueling endurance sport, while key disagreements remain unresolved.
A meta-analysis of 4,941 adults finds FTO risk-allele carriers have higher triglycerides on calorie-restricted diets, but most metabolic markers respond similarly across genotypes.
With 225+ clinical trials behind it, intermittent fasting rivals calorie restriction for type 2 diabetes — yet major guidelines still ignore it.
